Literature DB >> 9525925

The role of calcium and phosphorylation of cytosolic phospholipase A2 in regulating arachidonic acid release in macrophages.

Z H Qiu1, M A Gijón, M S de Carvalho, D M Spencer, C C Leslie.   

Abstract

Arachidonic acid release is induced in macrophages with diverse agonists including calcium ionophores, phorbol myristate acetate (PMA), okadaic acid, and the phagocytic particle, zymosan, and correlates with activation of cytosolic phospholipase A2 (cPLA2). The role of calcium and phosphorylation of cPLA2 in regulating arachidonic acid release was investigated. Zymosan induced a rapid and transient increase in [Ca2+]i. This in itself is not sufficient to induce arachidonic acid release since ATP and platelet activating factor (PAF), agonists that induce transient calcium mobilization in macrophages, induced little arachidonic acid release. Unlike zymosan, which is a strong activator of mitogen-activated protein kinase (MAPK), ATP and PAF were weak MAPK activators and induced only a partial and transient increase in cPLA2 phosphorylation (gel shift). However, ATP or PAF together with colony stimulating factor-1 (CSF-1) synergistically stimulated arachidonic acid release. CSF-1 is a strong MAPK activator that induces a rapid and complete cPLA2 gel shift but not calcium mobilization or arachidonic acid release. Arachidonic acid release was more rapid in response to CSF-1 plus ATP or PAF than zymosan and correlated with the time course of the cPLA2 gel shift. Although low concentrations of ionomycin induced a lower magnitude of calcium mobilization than ATP, the response was more sustained resulting in arachidonic acid release. A23187 and ionomycin induced weak MAPK activation, and a partial and transient cPLA2 gel shift. The MAPK kinase inhibitor, PD 98059 suppressed A23187-induced MAPK activation and cPLA2 gel shift but had little effect on arachidonic acid release. These results indicate that in macrophages a transient increase in [Ca2+]i and sustained phosphorylation of cPLA2 can act together to promote arachidonic acid release but neither alone is sufficient. A sustained increase in calcium is sufficient for inducing arachidonic acid release. However, PMA and okadaic acid induce arachidonic acid release without increasing [Ca2+]i, although resting levels of calcium are required, suggesting alternative mechanisms of regulation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9525925     DOI: 10.1074/jbc.273.14.8203

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  35 in total

1.  G-protein-gated inwardly rectifying potassium channels regulate ADP-induced cPLA2 activity in platelets through Src family kinases.

Authors:  Haripriya Shankar; Bryan N Kahner; Janani Prabhakar; Parth Lakhani; Soochong Kim; Satya P Kunapuli
Journal:  Blood       Date:  2006-07-20       Impact factor: 22.113

Review 2.  The glycerophosphoinositols: cellular metabolism and biological functions.

Authors:  Daniela Corda; Pasquale Zizza; Alessia Varone; Beatrice Maria Filippi; Stefania Mariggiò
Journal:  Cell Mol Life Sci       Date:  2009-08-09       Impact factor: 9.261

3.  JNK and ceramide kinase govern the biogenesis of lipid droplets through activation of group IVA phospholipase A2.

Authors:  Albert Gubern; Miquel Barceló-Torns; David Barneda; José M López; Roser Masgrau; Fernando Picatoste; Charles E Chalfant; Jesús Balsinde; María A Balboa; Enrique Claro
Journal:  J Biol Chem       Date:  2009-09-24       Impact factor: 5.157

4.  Polychlorinated biphenyls induce arachidonic acid release in human platelets in a tamoxifen sensitive manner via activation of group IVA cytosolic phospholipase A2-alpha.

Authors:  Pontus K A Forsell; Anders O Olsson; Erik Andersson; Laxman Nallan; Michael H Gelb
Journal:  Biochem Pharmacol       Date:  2005-11-14       Impact factor: 5.858

5.  Calpain cleaves phospholipid flippase ATP8A1 during apoptosis in platelets.

Authors:  Weidong Jing; Mehmet Yabas; Angelika Bröer; Lucy Coupland; Elizabeth E Gardiner; Anselm Enders; Stefan Bröer
Journal:  Blood Adv       Date:  2019-02-12

Review 6.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

Review 7.  Phospholipases A2 in ischemic and toxic brain injury.

Authors:  A Sapirstein; J V Bonventre
Journal:  Neurochem Res       Date:  2000-05       Impact factor: 3.996

8.  Role of phosphorylation and basic residues in the catalytic domain of cytosolic phospholipase A2alpha in regulating interfacial kinetics and binding and cellular function.

Authors:  Dawn E Tucker; Moumita Ghosh; Farideh Ghomashchi; Robyn Loper; Saritha Suram; Bonnie St John; Milena Girotti; James G Bollinger; Michael H Gelb; Christina C Leslie
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

9.  Extracellular calcium regulates HeLa cell morphology during adhesion to gelatin: role of translocation and phosphorylation of cytosolic phospholipase A2.

Authors:  J R Crawford; B S Jacobson
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

10.  Preconditioning with soluble guanylate cyclase activation prevents postischemic inflammation and reduces nitrate tolerance in heme oxygenase-1 knockout mice.

Authors:  Walter Z Wang; Allan W Jones; Meifang Wang; William Durante; Ronald J Korthuis
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-06-14       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.